Gatifloxacin ndamustine D4 4(1):e00558-12

4(1):e00558-12

2-PMPA at 250 mg/kg

The favorable pharmacokinetic profile of TAS-116 is reflected in its dose-dependent antitumor activity

Formula: C27H31Br2ClN4O2

JZL184 improves behavior and neural properties in Ts65Dn mice

Gatifloxacin ndamustine D4 4(1):e00558-12Gatifloxacin is an antibiotic of the fourth generation fluoroquinolone family that inhibits the bacterial enzymes DNA gyrase and topoisomerase IV. Gatifloxacin is a fluoroquinolone antibiotic, with potent activity against Gram negative and Gram positive bacteria. Bristol Myers Squibb introduced Gatifloxacin in 1999 under the proprietary name Tequin for the treatment of respiratory tract infections. Allergan produces it in eye drop formulation under